Finance

Lists
4583:TYO
Chiome Bioscience Inc
102,00 JP¥
-1,92%
(-2,00) 1D
2 қаз., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4583...
Open
103 JP¥
High
103 JP¥
Low
99 JP¥
Mkt. cap
8,35 млрд
Avg. vol.
2,51 млн
Volume
1,05 млн
52-wk high
142 JP¥
52-wk low
65 JP¥
EPS
-13 JP¥
Shares outstanding
26,78 млн
No. of employees
49
Open
103 JP¥
High
103 JP¥
Low
99 JP¥
Mkt. cap
8,35 млрд
Avg. vol.
2,51 млн
Volume
1,05 млн
52-wk high
142 JP¥
52-wk low
65 JP¥
EPS
-13 JP¥
Shares outstanding
26,78 млн
No. of employees
49
News stories
From web sources and news partners
News.com.au
News.com.au
·
31 минут бұрын
Giants ring bell at NYSE for 40th anniversary of SB 21
Simply Wall Street
Simply Wall Street
·
2 минут бұрын
Ionis Pharmaceuticals Fell 45% With The Case Still Split
Moomoo
Moomoo
·
29 минут бұрын
Chip-Led Rally Lifts Nasdaq; Tesla Jumps 4.65%
About Chiome Bioscience Inc
CEO-
Employees49
Founded2005 ж. 08 ақп.
Headquarters-
Sector-
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
118,02 млн
223,48 млн
147,16 млн
126,50 млн
Cost of goods sold
52,72 млн
72,06 млн
66,64 млн
48,50 млн
Cost of revenue
52,72 млн
72,06 млн
66,64 млн
48,50 млн
Research and development expenses
190,33 млн
190,34 млн
174,47 млн
194,51 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
143,50 млн
135,51 млн
138,40 млн
130,86 млн
Operating expense
333,83 млн
325,84 млн
312,87 млн
325,37 млн
Total operating expenses
386,54 млн
397,90 млн
379,51 млн
373,87 млн
Operating income
-268,52 млн
-174,43 млн
-232,34 млн
-247,37 млн
Other non operating income
-109,00 м.
-7,02 млн
-980,00 м.
-1,76 млн
EBT including unusual items
-259,15 млн
-181,72 млн
-232,34 млн
-249,28 млн
EBT excluding unusual items
-268,39 млн
-181,72 млн
-232,34 млн
-249,28 млн
Income tax expense
810,00 м.
810,00 м.
810,00 м.
810,00 м.
Effective tax rate
-0,31%
-0,45%
-0,35%
-0,32%
Other operating expenses
-
-
-
-
Net income
-259,96 млн
-182,53 млн
-233,15 млн
-250,09 млн
Net profit margin
-220,27%
-81,68%
-158,43%
-197,71%
Earnings per share
-
-
-
-
Interest and investment income
1,42 млн
126,00 м.
1,03 млн
123,00 м.
Interest expense
-959,00 м.
-256,00 м.
-292,00 м.
-313,00 м.
Net interest expenses
463,00 м.
-130,00 м.
739,00 м.
-190,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-268,23 млн
-173,49 млн
-231,41 млн
-244,96 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары